Community Academic Profiles–

Edward Riley

Back to Profile

Thromboelastography to assess hemostatic changes in patients undergoing elective Cesarean delivery.

Contact Information

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Primary Contact:

Alexander Butwick
To view all clinical trials at Stanford, please see the Clinical Trials Directory.

Brief

The purpose of the study is to assess the coagulation changes that occur in patients undergoing elective Cesarean delivery using thromboelastography (TEG). We will compare coagulation data to assess potential coagulation changes associated with hemoglobin changes before and after surgery, and related to estimated blood loss.

Recruiting Status:

Completed

Stanford Recruiting Status:

Completed

Condition(s):

Intervention(s):

Phase:

N/A

Eligibility

Ages Eligible for Study:

Any Age to Any Age

Genders Eligible for Study:

Female

Health of Volunteers:

People with the conditions listed in this trial can participate as controls.

Key Inclusion Criteria:

All obstetric patients with singleton pregnancies admitted to the labor and delivery unit at Lucille Packard
Hospital who undergo elective Cesarean delivery.
We will select 100 healthy ASA 1 patients with singleton pregnancies who are scheduled for uncomplicated
elective Cesarean delivery, with no anticipated risk of obstetric hemorrhage.

Key Exclusion Criteria:

Patients with underlying coagulation disorders.
Patients with thrombocytopenia.
Patients with pregnancy-induced hypertension, pre-eclampsia.
Patients requiring the following medications prior to surgery: NSAIDS, aspirin, anticoagulants.
Patients requiring non-elective Cesarean delivery.
Patients with significant obstetric or medical disease.
No patients <18 years of age will be recruited.

Additional Study Details

Official Title:

Thromboelastography to assess hemostatic changes in patients undergoing elective Cesarean delivery.

Anticipated start date:

8/25/2008

Lead Sponsor:

Stanford University

Investigator(s):

Study Type:

Observational

Purpose:

NOTNEEDED

Duration:

Longitudinal

Selection:

Defined Population

Timing:

Prospective

Total Number to be Enrolled:

60

Total Number to be Enrolled at Stanford:

60

More Information

Trial Unique Id: SU-08252008-1287

Secondary ID(s):

  • 11914

Locations & Contacts

Stanford Locations & Contacts:

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Primary Contact:

Alexander Butwick

Non-Stanford Locations:

The Stanford website does not have any locations outside of Stanford listed for this trial. You may want to check clinicaltrials.gov for posible additional locations.

This listing was last updated:

11/5/2009

PLEASE NOTE:

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician. If you do not have a primary care physician please feel free to call the SHC Physician Referral Service at (800) 756-9000 or send an email.

Stanford Medicine Resources:

Footer Links: